Revelation Biosciences, Inc.
REVB
$1.13
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.49% | 40.73% | 47.61% | 46.78% | -60.79% |
| Total Depreciation and Amortization | -5.90% | -2.87% | 5.19% | 10.34% | 14.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.88% | 453.78% | 4,654.69% | 506.11% | 176.02% |
| Change in Net Operating Assets | 105.47% | 99.83% | -106.07% | -238.86% | -584.04% |
| Cash from Operations | 52.46% | 54.86% | 39.37% | -96.08% | -113.80% |
| Capital Expenditure | -- | -- | 147.97% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 147.97% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 158.55% | -2.61% | 76.86% | 99.72% | 37.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 158.00% | -2.93% | 76.86% | 99.72% | 37.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 195.96% | 176.49% | 182.75% | -89.63% | -244.23% |